CinDome Pharma, a subsidiary of CinRx Pharma, has secured a $40 million extension to its Series B financing, raising...

Accenture Ventures, the venture capital arm of Accenture, has invested in Turbine, a predictive simulation company developing a platform...

A Phase IIa trial, known as COURSE, has assessed the effectiveness of TEZSPIRE (tezepelumab) in reducing COPD exacerbations in...

New data revealed that after four years of continuous treatment, over 70% of patients with psoriasis achieved a 75%...

Alpha Cognition Inc., a biopharmaceutical company focused on neurodegenerative disorders, has shared its financial results and updated it for...

FogPharma and ARTBIO have joined forces to develop a groundbreaking class of radioligand therapies (ARTs) that harness the power...

Oncodesign Precision Medicine (OPM) and Navigo Proteins GmbH have partnered to develop radiotheranostics, a targeted therapy that delivers radioactivity...

Bristol Myers Squibb’s Breyanzi has received accelerated FDA approval for adult patients with relapsed or refractory follicular lymphoma who...

Moffitt Cancer Center and Fulgent Pharma have formed a partnership to accelerate the development of personalized cancer therapies. •...

Syros Pharmaceuticals focused on hematologic malignancies and provided updates on its clinical progress, including the passing of the interim...